Christopher Holden, CEO of AmSurg, has sold 3,000 shares of company stock, according to WKRB News & Analysis report. David Manning, executive vice president of AmSurg, has sold 23,500 shares of company stock, according to a Mideast Times report.
Mr. Holden's stock sold at an average price of $47.37 per share, for a total transaction of $142,110. Mr. Holden now owns 285,198 company shares, which are valued at approximately $13.51 million.
Mr. Manning's stock sold at an average price of $48.55 per share, for a total transaction of $1.14 million. Mr. Manning now owns 108,203 company shares, which is an estimated value of $5.25 million.
Both transactions were disclosed in filings with the U.S. Securities and Exchange Commission.
More Articles on Transactions and Valuation Issues:
ASC Company Services & Ownership: 7 Things to Know
How Does Physician Ownership Impact ASC Valuation? Q&A With VMG's Aaron Murski
7 Statistics on ASC Offering Price
Mr. Holden's stock sold at an average price of $47.37 per share, for a total transaction of $142,110. Mr. Holden now owns 285,198 company shares, which are valued at approximately $13.51 million.
Mr. Manning's stock sold at an average price of $48.55 per share, for a total transaction of $1.14 million. Mr. Manning now owns 108,203 company shares, which is an estimated value of $5.25 million.
Both transactions were disclosed in filings with the U.S. Securities and Exchange Commission.
More Articles on Transactions and Valuation Issues:
ASC Company Services & Ownership: 7 Things to Know
How Does Physician Ownership Impact ASC Valuation? Q&A With VMG's Aaron Murski
7 Statistics on ASC Offering Price